Roux-en-Y胃旁路术后超声内镜引导下经胃干预:多中心经验
这项回顾性多中心研究纳入47例Roux-en-Y胃旁路术患者,共行54例次超声内镜引导下经胃干预(EDGI),技术成功52例(96%),不良事件5例(10.6%),其中仅1例(2.1%)为重度,LAMS锚定对支架移位具有保护作用(P=0.001)。
要点
- EDGI在RYGB患者中技术成功率达96%,重度不良事件发生率低(2.1%)。
- LAMS移位是最常见不良事件,锚定与LAMS移位风险降低相关(P=0.001)。
- LAMS移除后瘘管持续存在少见(2/17,11.7%),内镜下闭合似乎有效。
核心结论
- EDGI对RYGB患者的胰胆管及前肠疾病诊治有效且安全。
- EDGI技术成功率高、重度不良事件发生率低。
- LAMS移位是最常见不良事件,有证据表明锚定可预防其发生。
- 瘘管持续存在可能发生,但内镜下闭合似乎有效。
研究设计与样本
- 回顾性研究,纳入9个中心(美国8个、欧洲1个)。
- 纳入2015年6月至2021年9月期间接受EDGI的RYGB患者。
- 共47例患者接受54例次EDGI操作。
- 主要结局为EDGI技术成功,次要结局为不良事件、住院时间和瘘管随访与管理。
主要发现
- 患者平均年龄61岁,女性占72%。
- 最常见适应证为胰腺肿块评估(n=16)和胰腺液体积聚处理(n=10)。
- 26例使用20 mm LAMS,21例使用15 mm LAMS;37例建立胃胃吻合,10例建立空肠胃吻合。
- 30例(64%)行双 session EDGI,两次操作中位间隔17天;17例行单 session EDGI,其中10例(59%)行LAMS锚定。
- 最常见干预为诊断性EUS(伴或不伴FNA或细针活检取样;n=28)和EUS引导下囊肿胃吻合术(n=8),平均操作时间97.6±78.9分钟。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Placement of a lumen-apposing metal stent (LAMS) between the gastric pouch and the excluded stomach allows for EUS-guided transgastric interventions (EDGIs) in patients with Roux-en-Y gastric bypass (RYGB). Although EUS-guided transgastric ERCP (EDGE) outcomes have been reported, data are scant on other endoscopic interventions. We aimed to evaluate the outcomes and safety of EDGIs. METHODS: This retrospective study involved 9 centers (United States, 8; Europe, 1) and included patients with RYGB who underwent EDGIs between June 2015 and September 2021. The primary outcome was the technical success of EDGIs. Secondary outcomes were adverse events (AEs), length of hospital stay, and fistula follow-up and management. RESULTS: Fifty-four EDGI procedures were performed in 47 patients (mean age, 61 years; 72% women), most commonly for the evaluation of a pancreatic mass (n = 16) and management of pancreatic fluid collections (n = 10). A 20-mm LAMS was used in 26 patients and a 15-mm LAMS in 21, creating a gastrogastrostomy in 37 patients and jejunogastrostomy in 10. Most patients (n = 30, 64%) underwent a dual-session EDGI, with a median interval of 17 days between the 2 procedures. Single-session EDGI was performed in 17 patients, of whom 10 (59%) had anchoring of the LAMS. The most common interventions were diagnostic EUS (with or without FNA or fine-needle biopsy sampling; n = 28) and EUS-guided cystgastrostomy (n = 8). The mean procedural time was 97.6 ± 78.9 minutes. Technical success was achieved in 52 patients (96%). AEs occurred in 5 patients (10.6%), of which only 1 AE (2.1%) was graded as severe. Intraprocedural LAMS migration was the most common AE, occurring in 3 patients (6.4%), whereas delayed spontaneous LAMS migration occurred in 2 (4.3%). Four of the 5 LAMS migration events were managed endoscopically, and 1 required surgical repair. LAMS anchoring was found to be protective against LAMS migration (P = .001). The median duration of hospital stay was 2.1 ± 3.7 days. Of the 17 patients who underwent objective fistula assessment endoscopically or radiologically after LAMS removal, 2 (11.7%) were found to have persistent fistulas. In 1 case the fistula was intentionally left open to assist with weight gain. The other fistula was successfully closed endoscopically. CONCLUSIONS: EDGI is effective and safe for the diagnosis and management of pancreaticobiliary and foregut disorders in RYGB patients. It is associated with high rates of technical success and low rates of severe AEs. LAMS migration is the most common AE with evidence that anchoring can be protective against its occurrence. Persistent fistulas may occur, but endoscopic closure seems to be effective.
引用
- Ghandour B, Shinn B, Dawod QM, et al. EUS-directed transgastric interventions in Roux-en-Y gastric bypass anatomy: a multicenter experience. Gastrointest Endosc. 2022. PMID: 35623383. doi:10.1016/j.gie.2022.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。